encyclopedia of medical concepts
ψ 
ψ 
ψ 

Antibodies, Blocking

More information in Books or onNLM PubMed
Definition: Antibodies that inhibit the reaction between ANTIGEN and other antibodies or sensitized T-LYMPHOCYTES (e.g., antibodies of the IMMUNOGLOBULIN G class that compete with IGE antibodies for antigen, thereby blocking an allergic response). Blocking antibodies that bind tumors and prevent destruction of tumor cells by CYTOTOXIC T-LYMPHOCYTES have also been called enhancing antibodies. (Rosen et al., Dictionary of Immunology, 1989)  antibodies inhibiting reaction between antigen and other antibodies or sensitized T-lymphocytes: not for any antibody reaction to an antigen (   
Pharmacological Action Immunologic Factors
Other names Enhancing Antibodies; Blocking Antibodies; Antibodies, Enhancing
 
SubstanceCAS Registry & nameCategoriesSourceDrugs*
4C9 antibody, rat  0   *Antibodies, Blocking. J Pharm Sci. 2005 Apr;94(4):718-29
basiliximab  0   *Antibodies, Monoclonal *Recombinant Fusion Proteins Antibodies, Blocking.
Pharma Action Immunosuppressive Agents
Lancet 1997 Oct 25;350(9086):1193-8SIMULECT
blocking factor  0   *Antigens, Neoplasm Antibodies, Blocking. Obstet Gyn 48(5):590;1976; Proc Nat Acad Sci 74(10):4605;1977

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012

Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy